JPWO2023067501A5 - - Google Patents

Info

Publication number
JPWO2023067501A5
JPWO2023067501A5 JP2024523414A JP2024523414A JPWO2023067501A5 JP WO2023067501 A5 JPWO2023067501 A5 JP WO2023067501A5 JP 2024523414 A JP2024523414 A JP 2024523414A JP 2024523414 A JP2024523414 A JP 2024523414A JP WO2023067501 A5 JPWO2023067501 A5 JP WO2023067501A5
Authority
JP
Japan
Prior art keywords
human subject
pharmaceutical composition
mucositis
effective amount
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537906A (ja
JP2024537906A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060007 external-priority patent/WO2023067501A1/en
Publication of JP2024537906A publication Critical patent/JP2024537906A/ja
Publication of JPWO2023067501A5 publication Critical patent/JPWO2023067501A5/ja
Publication of JP2024537906A5 publication Critical patent/JP2024537906A5/ja
Pending legal-status Critical Current

Links

JP2024523414A 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法 Pending JP2024537906A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163257099P 2021-10-18 2021-10-18
US63/257,099 2021-10-18
PCT/IB2022/060007 WO2023067501A1 (en) 2021-10-18 2022-10-18 Compositions and methods for treating mucositis

Publications (3)

Publication Number Publication Date
JP2024537906A JP2024537906A (ja) 2024-10-16
JPWO2023067501A5 true JPWO2023067501A5 (https=) 2025-10-27
JP2024537906A5 JP2024537906A5 (https=) 2025-10-27

Family

ID=86057963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523414A Pending JP2024537906A (ja) 2021-10-18 2022-10-18 粘膜炎を処置するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240415798A1 (https=)
EP (1) EP4419096A4 (https=)
JP (1) JP2024537906A (https=)
KR (1) KR20240089762A (https=)
WO (1) WO2023067501A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158322A0 (en) * 2001-04-18 2004-05-12 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
KR20050118057A (ko) * 2004-04-24 2005-12-15 김상희 아세틸디아실글리세롤류의 화합물을 유효성분으로함유하는 항암제 및 건강식품
US9808438B2 (en) * 2015-11-09 2017-11-07 Enzychem Lifesciences Corporation Method for treating mucositis
PL3716967T3 (pl) * 2017-11-30 2023-12-11 Enzychem Lifesciences Corporation Kompozycje do zapobiegania lub leczenia ostrej choroby popromiennej

Similar Documents

Publication Publication Date Title
Rasmussen et al. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis
Guilhou et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients
Fischer et al. Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial
Scott et al. Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized study
CA3221808A1 (en) Egfr inhibitor for the treatment of head and neck cancer
JP7475398B2 (ja) 医学療法におけるセマグルチド
ÖzDEMIR et al. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis
Lombardi et al. Pentoxifylline and tocopherol for prevention of osteoradionecrosis in patients who underwent oral surgery: A clinical audit
CN103533940A (zh) 治疗晚期实体瘤的方法
KR20240032789A (ko) 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물
HARRELL et al. The treatment of North American blastomycosis with amphotericin B
JP2025166240A5 (https=)
Sommariva et al. Intravesical hyaluronic acid and chondroitin sulphate improve symptoms and quality of life in patients with late radiation tissue cystitis: an investigative pilot study
Köse et al. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor
Roayaei et al. The effect of oral zinc sulfate on prevention of chemotherapy-induced oral mucositis in breast cancer patients treated with adriamycin and cyclophosphamide; a double-blind randomized clinical trial
US5331012A (en) Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
TWI229599B (en) Kits for treating vulvovaginal candidiasis with miconazole nitrate
JPWO2023067501A5 (https=)
US7790203B2 (en) Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
KR100302994B1 (ko) 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용
Ashokkumar et al. Parotid abscess with facial palsy in a patient on hemodialysis: a management challenge
TW201244732A (en) Ezatiostat for treating multiple myeloma
CN111821423A (zh) 一种白介素2用于治疗慢性自发性荨麻疹的应用
JPWO2022093724A5 (https=)
Aliyeva et al. Contemporary Methods of Treatment for Palmoplantar Psoriasis: A Literature Review